Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

Al-Dewik, N, Morsi, HM, Samara, MM et al. (11 more authors) (2016) Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar? Clinical Medicine Insights: Oncology (10). pp. 95-104.

Abstract

Metadata

Authors/Creators:
  • Al-Dewik, N
  • Morsi, HM
  • Samara, MM
  • Ghasoub, RS
  • Gnanam, CC
  • Bhaskaran, SK
  • Nashwan, AJ
  • Al-Jurf, RM
  • Ismail, MA
  • AlSharshani, MM
  • AlSayab, AA
  • Ben-Omran, TI
  • Khatib, R
  • Yassin, MA
Copyright, Publisher and Additional Information: (c) the authors, publisher and licensee Libertas Academica Limited. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License.
Dates:
  • Published: 2 October 2016
  • Accepted: 26 May 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Healthcare (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 16 Dec 2016 15:12
Last Modified: 05 Oct 2017 16:24
Published Version: https://doi.org/10.4137/CMO.s32822
Status: Published
Publisher: Libertas Academica
Identification Number: https://doi.org/10.4137/CMO.s32822

Share / Export

Statistics